The effects of mild or moderate hepatic impairment on the pharmacokinetics, safety, and tolerability of naloxegol

Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain

(2014) William D. Chey et al.   NEW ENGLAND JOURNAL OF MEDICINE

A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation

(2013) Lynn Webster et al.   PAIN

Analgesics in Patients with Hepatic Impairment

(2012) Marija Bosilkovska et al.   DRUGS

Opioid-Induced Constipation: Challenges and Therapeutic Opportunities

(2011) Michael Camilleri   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

(2011) Kelly Posner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy

(2011) Ming Luo et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Pharmacotherapy for Hepatic Encephalopathy

(2010) Paula V. Phongsamran et al.   DRUGS

Pain Management in the Cirrhotic Patient: The Clinical Challenge

(2010) Natasha Chandok et al.   MAYO CLINIC PROCEEDINGS

Treatment Guidelines for Hepatic Encephalopathy

(2010) J. Richard Thompson   PHARMACOTHERAPY

The Prevalence, Severity, and Impact of Opioid-Induced Bowel Dysfunction: Results of a US and European Patient Survey (PROBE 1)

(2008) Timothy J. Bell et al.   PAIN MEDICINE

Meeting the Challenges of Opioid-Induced Constipation in Chronic Pain Management – A Novel Approach

(2008) Karen Reimer et al.   PHARMACOLOGY